| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/28/2005 | US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165072 used as analgesics, antiepileptics agents, antidepressants, antiarrhythmia agents and for treatment of irritable bowel syndrome, Cnohn's disease, multiple sclerosis and bipolar disorders |
| 07/28/2005 | US20050165063 Amine compounds and use thereof |
| 07/28/2005 | US20050165062 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165055 Novel substituted indoles |
| 07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
| 07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |
| 07/28/2005 | US20050165032 Vanilloid receptor ligands and their use in treatments |
| 07/28/2005 | US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165024 Urea derivatives as kinase modulators |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050165020 5-(2,6-Difluorobenzyloxymethyl)-5-methyl-3-(3-propylisoxazol-5-yl)-4,5-dihydroisoxazole, used as preemergence or postemergence plant growth regulators |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof |
| 07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | US20050164120 High photosensitivity, visible laser recording materials; comprised of novel squarylium compound metal complexes, free radical generators and monomers |
| 07/28/2005 | CA2552681A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | CA2552403A1 Benzimidazole derivatives |
| 07/28/2005 | CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/28/2005 | CA2551495A1 Conjugated small molecules |
| 07/28/2005 | CA2551415A1 Thiazole derivatives and use thereof |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557168A2 Biarylurea Derivatives |
| 07/27/2005 | EP1556445A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 07/27/2005 | EP1556388A2 A method for manufacture of ceftiofur |
| 07/27/2005 | EP1556381A1 Pyrazole amides for treating hiv infections |
| 07/27/2005 | EP1556378A1 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 07/27/2005 | EP1556377A1 Cyclopropyl-thienyl-carboxamide as fungicides |
| 07/27/2005 | EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 07/27/2005 | EP1556142A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 07/27/2005 | EP1556059A1 Thrombopoietin mimetics |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556032A1 Agent for preventing or treating neuropathy |
| 07/27/2005 | EP1414384A4 Synthesis of epothilones and relates analogs |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1315723B1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 07/27/2005 | EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/27/2005 | EP0929526B1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| 07/27/2005 | CN1646521A Substituted 4-hetaryl-pyrazolines as pest control agents |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646495A Amine compounds and use thereof |
| 07/27/2005 | CN1646489A Delta1-pyrrolines and their use as pestcidal |
| 07/27/2005 | CN1646016A Synergistic insecticidal mixtures |
| 07/27/2005 | CN1644585A Covalently linked oligonucleotide minor grove binder conjugates |
| 07/26/2005 | US6921821 Antagonists of melanin concentrating hormone receptor |
| 07/26/2005 | US6921769 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 07/26/2005 | US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/26/2005 | CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/21/2005 | WO2005066165A1 N-substituted piperidine and piperazine derivatives |
| 07/21/2005 | WO2005066163A2 Thiophene derivatives as chk 1 inihibitors |
| 07/21/2005 | WO2005066153A1 Tricyclic steroid hormone nuclear receptor modulators |
| 07/21/2005 | WO2005066147A1 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 07/21/2005 | WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators |
| 07/21/2005 | WO2005066137A1 2,5-diaryl-1h-imidazole-4-carboxamides as neurokinin-3 receptor modulators for the treatment of central nervous system and peripheral diseases |
| 07/21/2005 | WO2005066132A1 Therapeutic agents i |
| 07/21/2005 | WO2005066128A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | WO2005066126A1 Cb1 modulator compounds |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005065050A2 Bicyclic compound |
| 07/21/2005 | WO2005042712A3 Heterocyclic compounds and methods of making and using thereof |
| 07/21/2005 | WO2005026137A3 Modulators of atp-binding cassette transporters |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004087051A3 Ophthalmic compositions for treating ocular hypertension |
| 07/21/2005 | WO2004055004A8 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/21/2005 | US20050159599 Insecticides for soil/seed treatment |
| 07/21/2005 | US20050159598 Activators of human peroxisome proliferator activated receptors such as {2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methanol |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159473 3-Substituted oxindole beta3 agonists |
| 07/21/2005 | US20050159469 HIV protease inhibiting compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159462 Elevates extracellular adenosine concentration for antiinflammatory and immunosuppressive effects; reaction of imidazole-4-carboxamide with a hydroxyalkylbenzoxazole or benzothiazole compound; 1-[4-hydroxy-1-(2-phenyl-4-benzoxazolyl)-3-pentyl]-imidazole-4-carboxamide |
| 07/21/2005 | US20050159461 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester |
| 07/21/2005 | US20050159455 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159437 Pharmaceutical agents |
| 07/21/2005 | US20050159435 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 07/21/2005 | US20050159411 Bactericides for infrections in man |
| 07/21/2005 | US20050156753 Digital sound processing system for a vehicle |